Biomea Fusion, Inc. Profile Avatar - Palmy Investing

Biomea Fusion, Inc.

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioava…

Biotechnology
US, Redwood City [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Biomea Fusion, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Biomea Fusion, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Biomea Fusion, Inc..

End of BMEA's Analysis
CIK: 1840439 CUSIP: 09077A106 ISIN: US09077A1060 LEI: - UEI: -
Secondary Listings
BMEA has no secondary listings inside our databases.